• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用全基因组测序和基于芯片的方法分析不同血统中1型糖尿病遗传风险评分的差异。

Type 1 diabetes genetic risk score variation across ancestries using whole genome sequencing and array-based approaches.

作者信息

Arni Ankit M, Fraser Diane P, Sharp Seth A, Oram Richard A, Johnson Matthew B, Weedon Michael N, Patel Kashyap A

机构信息

Department of Clinical and Biomedical Sciences, RILD Building, Royal Devon and Exeter Hospital, University of Exeter, Barrack Road, Exeter, EX2 5DW, UK.

Department of Pediatrics, Stanford University, Stanford, CA, 94305, USA.

出版信息

Sci Rep. 2024 Dec 28;14(1):31044. doi: 10.1038/s41598-024-82278-x.

DOI:10.1038/s41598-024-82278-x
PMID:39730838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11680773/
Abstract

A Type 1 Diabetes Genetic Risk Score (T1DGRS) aids diagnosis and prediction of Type 1 Diabetes (T1D). While traditionally derived from imputed array genotypes, Whole Genome Sequencing (WGS) provides a more direct approach and is now increasingly used in clinical and research studies. We investigated the concordance between WGS-based and array-based T1DGRS across genetic ancestries in 149,265 UK Biobank participants using WGS, TOPMed-imputed, and 1000 Genomes-imputed array genotypes. In the overall cohort, WGS-based T1DGRS demonstrated strong correlation with TOPMed-imputed array-based score (r = 0.996, average WGS-based score 0.0028 standard deviations (SD) lower, p < 10), while showing lower correlation with 1000 Genomes-imputed array-based scores (r = 0.981, 0.043 SD lower in WGS, p < 10). Ancestry-stratified analyses between WGS-based and TOPMed-imputed array-based score showed the highest correlation with European ancestry (r = 0.996, 0.044 SD lower in WGS, p < 10) followed by African ancestry (r = 0.989, 0.0193 SD lower in WGS, p < 10) and South Asian ancestry (r = 0.986, 0.0129 SD lower in WGS, p < 10 ). These differences were more pronounced when comparing WGS based score with 1000 Genomes-imputed array-based scores (r = 0.982, 0.975, 0.957 for European, South Asian, African respectively). Population-level analysis using WGS-based T1DGRS revealed significant ancestry-based stratification, with European ancestry individuals showing the highest scores, followed by South Asian (average 0.28 SD lower than Europeans, p < 10) and African ancestry individuals (average 0.89 SD lower than Europeans, p < 10). Notably, when applying the European ancestry-derived 90 centile risk threshold, only 0.71% (95% CI 0.41-1.13) of African ancestry individuals and 6.4% (95% CI 5.6-7.2) of South Asian individuals were identified as high-risk, substantially below the expected 10%. In conclusion, while WGS is viable for generating T1DGRS, with TOPMed-imputed genotypes offering a cost-effective alternative, the persistence of ancestry-based variations in T1DGRS distribution even using whole genome sequencing emphasises the need for ancestry-specific or pan-ancestry standards in clinical practice.

摘要

1型糖尿病遗传风险评分(T1DGRS)有助于1型糖尿病(T1D)的诊断和预测。传统上,T1DGRS是从推算的阵列基因型得出的,而全基因组测序(WGS)提供了一种更直接的方法,现在越来越多地用于临床和研究。我们使用WGS、TOPMed推算基因型和千人基因组计划推算的阵列基因型,在149,265名英国生物银行参与者中,研究了基于WGS和基于阵列的T1DGRS在不同遗传血统中的一致性。在整个队列中,基于WGS的T1DGRS与基于TOPMed推算的阵列评分显示出强相关性(r = 0.996,基于WGS的平均评分低0.0028个标准差(SD),p < 10),而与基于千人基因组计划推算的阵列评分相关性较低(r = 0.981,WGS中低0.043 SD,p < 10)。基于WGS和基于TOPMed推算的阵列评分之间的血统分层分析显示,与欧洲血统的相关性最高(r = 0.996,WGS中低0.044 SD,p < 10),其次是非洲血统(r = 0.989,WGS中低0.0193 SD,p < 10)和南亚血统(r = 0.986,WGS中低0.0129 SD,p < 10)。当将基于WGS的评分与基于千人基因组计划推算的阵列评分进行比较时,这些差异更为明显(欧洲、南亚、非洲血统的r分别为0.982、0.975、0.957)。使用基于WGS的T1DGRS进行的人群水平分析显示,存在显著的基于血统的分层,欧洲血统个体的评分最高,其次是南亚血统个体(平均比欧洲人低0.28 SD,p < 10)和非洲血统个体(平均比欧洲人低0.89 SD,p < 10)。值得注意的是,当应用源自欧洲血统的第90百分位风险阈值时,只有0.71%(95% CI 0.41 - 1.13)的非洲血统个体和6.4%(95% CI 5.6 - 7.2)的南亚个体被确定为高风险,大大低于预期的10%。总之,虽然WGS可用于生成T1DGRS,TOPMed推算基因型提供了一种经济有效的替代方法,但即使使用全基因组测序,T1DGRS分布中基于血统的差异仍然存在,这强调了在临床实践中需要特定血统或泛血统标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/050cae111de4/41598_2024_82278_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/bc13a2daa29c/41598_2024_82278_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/f0a8159aaae9/41598_2024_82278_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/050cae111de4/41598_2024_82278_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/bc13a2daa29c/41598_2024_82278_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/f0a8159aaae9/41598_2024_82278_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c713/11680773/050cae111de4/41598_2024_82278_Fig3_HTML.jpg

相似文献

1
Type 1 diabetes genetic risk score variation across ancestries using whole genome sequencing and array-based approaches.利用全基因组测序和基于芯片的方法分析不同血统中1型糖尿病遗传风险评分的差异。
Sci Rep. 2024 Dec 28;14(1):31044. doi: 10.1038/s41598-024-82278-x.
2
Extent to which array genotyping and imputation with large reference panels approximate deep whole-genome sequencing.基于大型参考面板的基因分型和模拟深度全基因组测序的程度。
Am J Hum Genet. 2022 Sep 1;109(9):1653-1666. doi: 10.1016/j.ajhg.2022.07.012. Epub 2022 Aug 17.
3
Whole-Genome Sequencing Association Analyses of Stroke and Its Subtypes in Ancestrally Diverse Populations From Trans-Omics for Precision Medicine Project.基于精准医学项目的跨组学研究,对来自不同祖先人群的中风及其亚型进行全基因组测序关联分析。
Stroke. 2022 Mar;53(3):875-885. doi: 10.1161/STROKEAHA.120.031792. Epub 2021 Nov 3.
4
Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations.超过 10 万 NHLBI 转化医学精准医学(TOPMed)联盟全基因组序列的使用提高了混合非裔和西班牙裔/拉丁裔人群中罕见变异关联的推断质量和检测能力。
PLoS Genet. 2019 Dec 23;15(12):e1008500. doi: 10.1371/journal.pgen.1008500. eCollection 2019 Dec.
5
Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts.全基因组测序在多血统队列中鉴定 CRP 基因座的等位基因异质性。
Am J Hum Genet. 2020 Jan 2;106(1):112-120. doi: 10.1016/j.ajhg.2019.12.002. Epub 2019 Dec 26.
6
Cross-ancestry genome-wide association studies identified heterogeneous loci associated with differences of allele frequency and regulome tagging between participants of European descent and other ancestry groups from the UK Biobank.跨种族全基因组关联研究确定了与英国生物库中欧洲血统和其他血统群体参与者之间等位基因频率差异和调控标记相关的异质位点。
Hum Mol Genet. 2021 Jul 9;30(15):1457-1467. doi: 10.1093/hmg/ddab114.
7
Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.低覆盖度全基因组测序可实现常见变异的精确评估和全基因组多基因评分的计算。
Genome Med. 2019 Nov 26;11(1):74. doi: 10.1186/s13073-019-0682-2.
8
Polygenic prediction of major depressive disorder and related traits in African ancestries UK Biobank participants.非洲裔英国生物银行参与者中重度抑郁症及相关性状的多基因预测
Mol Psychiatry. 2025 Jan;30(1):151-157. doi: 10.1038/s41380-024-02662-x. Epub 2024 Jul 16.
9
MagicalRsq: Machine-learning-based genotype imputation quality calibration.MagicalRsq:基于机器学习的基因型数据质量校准。
Am J Hum Genet. 2022 Nov 3;109(11):1986-1997. doi: 10.1016/j.ajhg.2022.09.009. Epub 2022 Oct 4.
10
Whole genome sequence analyses of eGFR in 23,732 people representing multiple ancestries in the NHLBI trans-omics for precision medicine (TOPMed) consortium.在 NHLBI 转化组学精准医学(TOPMed)联盟中,对代表多种血统的 23732 人的 eGFR 进行全基因组序列分析。
EBioMedicine. 2021 Jan;63:103157. doi: 10.1016/j.ebiom.2020.103157. Epub 2021 Jan 6.

引用本文的文献

1
Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies.跨多项筛查研究的1型糖尿病多变量预测模型的开发与重新校准,用于预测1型糖尿病。
BMC Med. 2025 Jul 21;23(1):433. doi: 10.1186/s12916-025-04225-5.
2
Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score.1型糖尿病多血统多基因风险评分的开发与验证
medRxiv. 2025 Jun 22:2025.06.20.25329522. doi: 10.1101/2025.06.20.25329522.

本文引用的文献

1
The GenoPred pipeline: a comprehensive and scalable pipeline for polygenic scoring.GenoPred 管道:一种全面且可扩展的多基因评分管道。
Bioinformatics. 2024 Oct 1;40(10). doi: 10.1093/bioinformatics/btae551.
2
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.基于结局导向的聚类分析识别 1 型糖尿病风险表型。
Diabetologia. 2024 Nov;67(11):2507-2517. doi: 10.1007/s00125-024-06246-w. Epub 2024 Aug 6.
3
The challenges of identifying and studying type 1 diabetes in adults.成人 1 型糖尿病的识别和研究面临的挑战。
Diabetologia. 2023 Dec;66(12):2200-2212. doi: 10.1007/s00125-023-06004-4. Epub 2023 Sep 20.
4
Utility of genetic risk scores in type 1 diabetes.遗传风险评分在 1 型糖尿病中的应用。
Diabetologia. 2023 Sep;66(9):1589-1600. doi: 10.1007/s00125-023-05955-y. Epub 2023 Jul 13.
5
Performance and accuracy evaluation of reference panels for genotype imputation in sub-Saharan African populations.撒哈拉以南非洲人群中基因型填补参考面板的性能与准确性评估
Cell Genom. 2023 May 23;3(6):100332. doi: 10.1016/j.xgen.2023.100332. eCollection 2023 Jun 14.
6
The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.TOPMed 插补在发现与 2 型糖尿病相关的拉丁裔丰富罕见变异中的作用。
Diabetologia. 2023 Jul;66(7):1273-1288. doi: 10.1007/s00125-023-05912-9. Epub 2023 May 6.
7
Elastic Net Regularization Paths for All Generalized Linear Models.所有广义线性模型的弹性网络正则化路径
J Stat Softw. 2023;106. doi: 10.18637/jss.v106.i01. Epub 2023 Mar 23.
8
Benchmarking challenging small variants with linked and long reads.使用连锁读段和长读段对具有挑战性的小变异进行基准测试。
Cell Genom. 2022 May;2(5). doi: 10.1016/j.xgen.2022.100128.
9
Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches.在缺乏分类生物标志物的研究数据集中识别1型和2型糖尿病:评估已发表方法的准确性。
J Clin Epidemiol. 2023 Jan;153:34-44. doi: 10.1016/j.jclinepi.2022.10.022. Epub 2022 Nov 9.
10
Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics.1 型糖尿病患者胰岛自身抗体水平分布及其与遗传和临床特征的关系。
J Clin Endocrinol Metab. 2022 Nov 25;107(12):e4341-e4349. doi: 10.1210/clinem/dgac507.